Macroview Investment Management’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-128
Closed -$3K 338
2020
Q2
$3K Sell
128
-57
-31% -$1.32K 0.01% 185
2020
Q1
$3K Buy
185
+155
+517% +$2.83K 0.01% 174
2019
Q4
$1K Hold
30
﹤0.01% 287
2019
Q3
$1K Hold
30
﹤0.01% 278
2019
Q2
$1K Hold
30
﹤0.01% 289
2019
Q1
$1K Hold
30
﹤0.01% 315
2018
Q4
$1K Sell
30
-212
-88% -$3.78K ﹤0.01% 301
2018
Q3
$4K Buy
242
+53
+28% +$1.03K 0.01% 171
2018
Q2
$4K Buy
189
+159
+530% +$3.29K 0.01% 160
2018
Q1
$1K Buy
+30
New +$829 ﹤0.01% 225

Other funds holding EXEL

Macroview Investment Management's EXEL Position: Q3 2020 in Review

Macroview Investment Management sold out of Exelixis (EXEL) in Q3 2020, closing a stake of 128 shares — an estimated $3K sold.

Macroview Investment Management first reported a position in EXEL in Q1 2018 and held it in 10 quarters. The position peaked at $4K in Q3 2018. 367 funds tracked by Wall St. Rank hold EXEL as of Q3 2020.

  • Macroview Investment Management reported no remaining Exelixis position as of Q3 2020 after selling out during the quarter.
  • Macroview Investment Management sold 128 Exelixis shares in Q3 2020, an estimated $3K.
  • Macroview Investment Management first reported a position in Exelixis in Q1 2018 and held it in 10 quarters.
  • Macroview Investment Management's Exelixis position peaked at $4K in Q3 2018.
  • 367 funds tracked by Wall St. Rank held Exelixis as of Q3 2020.

Based on Macroview Investment Management's 13F filing for Q3 2020, filed 23 Oct 2020.